COMMUNIQUÉS West-GlobeNewswire

CV Sciences, Inc. Files Application for Up-Listing to the NASDAQ Capital Market
23/07/2018
LAS VEGAS, July 23, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI), preeminent supplier and manufacturer of hemp-derived phytocannabinoids including cannabidiol (CBD) oil and developer of specialty [...]
SELLAS To Present Data from Phase 2b Trial of NeuVax + Herceptin® at Upcoming European Society for Medical Oncology (ESMO) 2018 Meeting
23/07/2018
Oral Presentation of NeuVax + Herceptin in the Adjuvant Treatment of Triple-Negative Breast Cancer Conference Scheduled for October 19-23, 2018 in Munich, Germany NEW YORK, July 23, 2018 (GLOBE NEWSWIRE) -- SELLAS Life [...]
OraSure Technologies, Inc. Appoints Vice President, Corporate Communications
23/07/2018
BETHLEHEM, Pa., July 23, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostics and specimen collection devices, today announced that Jeanne Mell has been appointed as [...]
Scythian Biosciences Corp. Announces Strategic Partnership for Cannabis in Brazil with one of the Founders of the Country’s Pharma Industry
23/07/2018
Company Strategically Positioned to Lead the Future of Cannabis for Medicinal Purposes for Brazil’s More Than 200 Million Population TORONTO, July 23, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (to be renamed [...]
Histogenics Chief Operating Officer, Stephen Kennedy Appointed to Advanced Regenerative Manufacturing Institute’s Technology Advisory Sub-Committee
23/07/2018
WALTHAM, Mass., July 23, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and restored [...]
Rubius Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
23/07/2018
CAMBRIDGE, Mass., July 23, 2018 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a biotechnology company pioneering the development of a new class of ready-to-use cellular therapies, today announced the [...]
CFN Media Launches Inaugural Episode of CFN Weekly
23/07/2018
SEATTLE, July 23, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces the launch of a new weekly news show [...]
MedTainer Orders Continue to Grow; More LPs Choosing Acology
23/07/2018
CORONA, Calif., July 23, 2018 (GLOBE NEWSWIRE) -- Acology Inc. (OTCMARKETS:ACOL) announced today that orders for its signature product, the MedTainer™, continue to increase beyond the record pace set for the same [...]
Allena Pharmaceuticals Announces First Patients Treated in Phase 2 Basket Study of ALLN-177 in Patients with Primary Hyperoxaluria or Enteric Hyperoxaluria and Advanced Chronic Kidney Disease
23/07/2018
U.S. Clinical Study Sites Enrolling Patients with Systemic Oxalate Burden; European Sites Prepared to Enroll Patients in Third Quarter of 2018 NEWTON, Mass., July 23, 2018 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc [...]
Brooke Donaldson, MD is Appointed to the American Health Council’s Board of Physicians
23/07/2018
NEW YORK, July 23, 2018 (GLOBE NEWSWIRE) -- Brooke Donaldson, MD has been appointed to the American Health Council’s Board of Physicians. Dr. Donaldson currently serves as the Genesis Peer Support clinical chairwoman, [...]
Immunomedics Announces Clinical Collaboration With AstraZeneca in First-Line Triple-Negative Breast and Urothelial Cancers
23/07/2018
Phase 1/2 Studies will Evaluate the Combination of Imfinzi® (Durvalumab) and Sacituzumab Govitecan in Previously-Untreated Patients with Triple-negative Breast Cancer and Urothelial Cancer MORRIS PLAINS, N.J., July 23, [...]
PetMed Express D/B/A 1-800-PetMeds Announces Record Earnings for Its First Fiscal Quarter and Its Increased Quarterly Dividend of $0.27 Per Share
23/07/2018
First Quarter Net Income Increased 36% First Quarter Sales Increased 10% First Quarter Diluted EPS $0.62 per share vs $0.45 per share DELRAY BEACH, Fla., July 23, 2018 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: [...]
Savara to Ring Nasdaq Stock Market Opening Bell on July 23rd
23/07/2018
AUSTIN, Texas, July 23, 2018 (GLOBE NEWSWIRE) -- Savara Inc. (Nasdaq:SVRA), an orphan lung disease company, announced today that Rob Neville, CEO of Savara, alongside key members of senior management, company directors [...]
ContraVir Pharmaceuticals Reports Progress in Phase 1/2A Trial of CRV431
23/07/2018
Data from the First Patient Cohort Indicate CRV431 is Safe and Well Tolerated EDISON, N.J., July 23, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the [...]
Tabula Rasa HealthCare’s SinfoníaRx Releases RxCompanion™ 10.0 Software
23/07/2018
Enhances User Experience to Maximize Outcomes MOORESTOWN, N.J., July 23, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ:TRHC), a healthcare technology company optimizing medication safety, today [...]
Rhythm Pharmaceuticals Receives European Medicines Agency PRIME Designation for Setmelanotide in Rare Genetic Disorders of Obesity
23/07/2018
-- Program Offers Enhanced Support for Development of Medicines that Target Unmet Medical Needs -- BOSTON, July 23, 2018 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company [...]
Leap Therapeutics Announces Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to Evaluate Combination of TRX518, Avelumab, and Chemotherapy in Advanced Solid Tumors
23/07/2018
CAMBRIDGE, Mass., July 23, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced it has entered into a [...]
Paratek Pharmaceuticals to Report Second Quarter 2018 Financial Results on August 2, 2018
23/07/2018
BOSTON, July 23, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline [...]
RedHill Biopharma Announces Uplisting to Nasdaq Global Market
23/07/2018
TEL-AVIV, Israel and RALEIGH, N.C., July 23, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]

Pages